Dapp Vaccine

Verify with FDA CVM →

191 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
191
Total Reports
30
Deaths Reported
1570.0%
Death Rate

Active Ingredients

Dapp Vaccine

Administration Routes

UnknownSubcutaneousOral

Species Affected

Dog 191

Most Affected Breeds

Retriever - Labrador 22
Chihuahua 18
Terrier - Yorkshire 17
Retriever - Golden 13
Terrier - Bull - American Pit 11
Bulldog - French 5
Dachshund (unspecified) 5
Shepherd Dog - Australian 5
Siberian Husky 4
Beagle 4

Most Reported Reactions

Vomiting 52
Facial swelling (see also Skin) 29
Lethargy (see also Central nervous system depression in Neurological) 29
Diarrhoea 27
Anaphylaxis 22
Seizure NOS 22
Hives (see also Skin) 20
Death by euthanasia 15
Lethargy (see also Central nervous system depression in 'Neurological') 14
Death 14
Decreased appetite 13
Fever 13

Outcome Breakdown

Ongoing
92 (48.2%)
Recovered/Normal
58 (30.4%)
Died
15 (7.9%)
Euthanized
15 (7.9%)
Outcome Unknown
11 (5.8%)

Data Summary

Metric Value
Total adverse event reports 191
Reports involving death 30
Case-fatality rate (reported events) 1570.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Dapp Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 191 adverse event reports referencing Dapp Vaccine, including 30 reports in which the animal died — a 1570.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Dapp Vaccine. Reported administration routes include Unknown, Subcutaneous, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Dapp Vaccine reports are Dog (191 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (22), Chihuahua (18), Terrier - Yorkshire (17) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Dapp Vaccine are Vomiting (52), Facial swelling (see also Skin) (29), Lethargy (see also Central nervous system depression in Neurological) (29), Diarrhoea (27). Of the 191 reports with a coded outcome, Ongoing is the leading category at 48.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Dapp Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial